Zdrowie i gospodarka · 09/03/1994

FDA Extends Comment Period for In Vitro Diagnostic Products Manufacturing Guideline

The Food and Drug Administration (FDA) is extending the comment period on a final guideline for the manufacture of In Vitro Diagnostic Products to April 11, 1994, to ensure adequate time for comments.